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Summary Cytogenetic analysis of short-term cultures from seven pulmonary hamartomas revealed an abnor-
mal karyotype in six of them. The most characteristic aberration was an exchange of material between 6p21
and 14q24, found in three tumours. Abnormalities of either 6p or 14q were seen in another two hamartomas.
Other regions that were rearranged more than once were 12q (three times) and 17p (twice), sometimes in
exchange with 6p or 14q and giving rise to complex derivative chromosomes. Only one tumour had
aberrations that did not involve 6p, 12q, 14q, or 17p. These results - together with the data on three
previously reported pulmonary hamartomas, two of which also had t(6;14) - show that recombinations
between 6p2l and 14q24 are common, and hence probably pathogenetically important. The data support the
view that these tumours are genuine neoplasms rather than developmental anomalies. The coexistence of a
common 14q24 breakpoint in uterine leiomyomas and pulmonary hamartomas indicates that a gene important
in the genesis of both tumours exists in this band.
Hamartomas are the most common tumourous lesions of the
lung, occurring in approximately 0.3% of the general popula-
tion (Koutras et al., 1971). They are usually peripherally
situated, grow slowly, and are invariably benign. The tum-
ours are well circumscribed and consist of focal overgrowths
of tissues normally present in the lung, such as cartilage,
smooth muscle, other connective tissue elements, and res-
piratory tract epithelium (Koss, 1990). The relative propor-
tions of these components may vary from case to case, which
has led to a quantitative classification of hamartomas into
chondromatous and leiomyomatous (WHO, 1982). Mostly,
the cartilaginous tissue predominates.
The pathogenetic nature of hamartomas has been a much-
contended issue. Are they developmental anomalies or
genuine neoplasms? The former view long prevailed, but
arguments for a neoplastic origin seem to have gained in
strength in later decades (Butler & Kleinerman, 1969; Bate-
son, 1973; Stone & Churg, 1976; Perez-Atayde & Seiler,
1984). If hamartomas are neoplastic, then the next question
must be whether they are truly biphasic tumours - i.e., both
the epithelial and mesenchymal components are part of the
neoplastic parenchyma - or monophasic, in which case either
the epithelium or the tumour's connective tissue is the essen-
tial element driving the neoplastic growth. The concept of
lung hamartomas as primarily mesenchymal tumours has
latterly come to dominate, and whatever non-mesenchymal
components they contain are seen as stemming from preexist-
ing airway epithelium entrapped as clefts when the tumour
grows (Bateson, 1973; Inze & Lui, 1977; Tomashefski, 1982;
Perez-Atayde & Seiler, 1984).
It is now widely accepted that neoplastic transformation is
brought about by somatic cell mutations occurring in a
limited set of genes that are crucial in proliferation and
differentiation. Often the relevant mutations are seen at the
cytogenetic level, and more and more characteristic abnor-
malities have been described also in solid tumours (Heim &
Mitelman, 1992). In this report we describe the detection of
acquired, specific, clonal chromosome aberrations in a series
of hamartomas of the lung. This argues strongly in favour of
a neoplastic genesis of such tumours. The nature of the
chromosomal anomalies indicates that pulmonary hamar-
tomas and uterine leiomyomas are tumourigenetically related.
Materials and methods
A brief summary of the clinical characteristics of the seven
cases is given in Table I. In all cases, the histological picture
was one of mature cartilage mixed with smooth muscle fibres
and occasional epithelial clefts (Figure 1). The cartilage com-
ponent dominated and so the diagnosis was cartilaginous
pulmonary hamartoma. Cases 1 and 3-7 were processed in
Lund, case 2 in Odense. Fresh tumour specimens were
minced with scissors and enzymatically disaggregated in col-
lagenase II (1 400 U ml-') for 2-5 h. The resulting cell
suspension was in cases I and 3-7 plated on glass chamber
slides in RPMI 1640 medium with HEPES buffer, supple-
mented with 10% foetal calf serum, L-glutamine (0.24mg
ml-'), insulin (5 fig ml1 '), epithelial growth factor
(1 ng ml-'), hydrocortisone (0.36 ig ml1), streptomycin
(200 .tg ml-'), and penicillin (100 IU ml-'). The cultures were
harvested in situ after 3-10 days by Colcemid (0.02 jLg ml-')
exposure for 4-5 h followed by hypotonic treatment in 0.3%
NaCl and gradual fixations in methanol:acetic acid (3:1).
In case 2, short-term cultures were initiated in plastic flasks
(Primaria-modified surface, Falcon) in Dulbecco's Modified
Eagle Medium:Ham's Nutrient Mixture F12 (1:1) with
HEPES buffer supplemented with foetal calf serum (20%),
L-glutamine (0.44 mg ml-'), penicillin (100 IU ml-'), strep-
tomycin (100 ig ml-'), epidermal growth factor (20 ng ml-'),
hydrocortisone (0.5jigrml-'), fetuin (20jigm -'), phosphoe-
thanolamine (0.1 mM), cholera toxin (100 ng ml-'), ascorbic
acid (10 ig ml-'), dibutyl cyclic acid AMP (1OnM), fibronec-
tin (100 ng ml-'), triiodothyronine (10 nM), trace element mix
(Gibco) (1 jil ml-'), and 1% ITS+ (Collaborative Research)
giving final concentrations of 6.25jigrml-' insulin, 6.25ng
ml-' selenious acid, 5.35 jig ml-' linoleic acid, 1.25 mg ml-'
bovine serum albumin, and 6.25 jig ml-' transferrin. After 3
days, the cultures were exposed to Colcemid (0.01 jig ml-')
for 6 h and harvested by hypotonic treatment in 0.05 M KCI
and repeated fixations in methanol:acetic acid (3:1).
The slides from all cases were incubated overnight at 6O°C,
treated for 4 h in 2 x SSC at 60°C and then G-banded with
Wright's stain. The subsequent chromosome analysis fol-
lowed the recommendations of the ISCN (1991).
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Table I Summary of clinical data and cytogenetic findings in the seven cartilaginous pulmonary
hamartomas
Case Sex/Age Site (lobe) Size (cm) Karyotype
1 F/31 Left upper 2 46,XX,del(6)(p21),der(14)t(6;14)(p21;q24)[17]
2 F/59 Right upper 4 47,XX,del(6)(p21),+ 8,der(14)inv(14)(p13q24)t(6;14)
(p21;q24)[48]
3 M/26 Right upper I 46,XY,der(1)ins(1;12)(p22p36;q24ql3),t(6;17;13;14)
(p21;p12;q14;q24)[23]
4 F/65 Right upper 2 46,XX,t(12;17)(q5;pll),del(14)(q22)[25]
5 F/74 Left lower 1 46,XX,ins(6;12)(p12p21;q14q13)[24]
6 M/38 Left upper 2 46,XY,add(l)(q43),del(3)(q27),del(8)(pllpl2)[24]
7 F/49 Right middle 2 46,XX[25]
Figure 1 Histological sections (haematoxylin-eosin; original magnification x 256) of the chondromatous hamartoma of case 2. A
characteristic picture of cartilage (left), and smooth muscle and epithelial clefts (right), is seen.
Results
Clonal chromosome abnormalities were found in six of the
seven hamartomas (Table I, Figures 2-4). Chromosomal
arms that were rearranged more than once were 6p and 14q
(four tumours each), 12q (three tumours), and 17p (two
tumours). In cases 1-3, chromosome material had been ex-
changed between 6p2l and 14q24, but never by means of a
simple, balanced two-way translocation. In case 3, a der(6)t
(6;14) (p21;q24) resulted, whereas a der(14)t(6;14) (p21;q24)
was generated in cases 1 and 2 (Figures 2-4; in case 2, an
additional inversion in the derivative chromosome 14 had
also occurred).
Discussion
Although some examples exist to the contrary (Johansson et
al., 1993), in general the rule holds that whenever acquired,
clonal chromosome abnormalities are found, this means that
the investigated disease process is neoplastic (Heim & Mitel-
man, 1987; Sandberg, 1990). Clonal chromosome aberrations
have previously been described in three pulmonary hamar-
tomas (Fletcher et al., 1991; Johansson et al., 1992). With the
series of tumours we describe now, it must be accepted as a
fact that most hamartomas of the lung are characterized by
abnormal karyotypes. This strongly supports the view that
they are genuine neoplasms, not just focal overgrowths of
disorganized but otherwise normal lung tissue.
Not only do pulmonary hamartomas have clonal chromo-
somal abnormalities, but the aberrations they contain are
nonrandomly distributed throughout the genome. Various
recombinations between 6p and 14q, sometimes leading to a
der(6)t(6;14) (p21;q24) and sometimes to a der(14)t(6;14)
(p21;q24), were found in three of the six tumours with abnor-
mal karyotypes, and other changes of 6p and 14q in two of
the remaining cases. Chromosomal arms 12q and 17p also
appeared to be the sites of nonrandom recombination, being
rearranged in three and two cases, respectively. When our
findings in the present series are compared with previously1238 M. JOHANSSON et al.
Figure 2 Representative karyogram from case 2. The arrowheads indicate rearranged chromosomes. The aberrations are del(6)
(p21), + 8, and der(14)inv(14)(p13q24)t(6;14)(p21;q24).
reported chromosomal data on pulmonary hamartomas, the
conclusion is strengthened that recombination of 6p2l and
14q24 is the primary karyotypic abnormality of these tum-
ours: Fletcher et al. (1991) described a t(6;14) (p21;q24) in
one of two hamartomas of the lung and we have described a
t(3;6;14) (p21;p21;q24) as the sole aberration in another pul-
monary hamartoma (Johansson et al., 1992). Thus, of the
nine karyotypically abnormal hamartomas of the lung avail-
able for evaluation, five have had rearrangements of 6p2l
and 14q24 with translocations of the distal part of 6p to the
der(14) or, less frequently, translocation of the distal part of
14q to the der(6). We suggest that the other rearrangements
of 6p and 14q seen in pulmonary hamartomas constitute
pathogenetically equivalent variants of the standard t(6;14).
Non-pulmonary hamartomas, on the other hand, seem to
have different karyotypic characteristics; the two liver hamar-
tomas described by Speleman et al. (1989) and Mascarello &
Krous (1992) had no 6;14-translocation but instead contained
rearrangements of 19ql3.
When comparing the karyotypic profile of pulmonary
hamartomas with that of other solid tumours, it seems
reasonable to look primarily at tumours whose histogenesis is
similar to the dominant tissue elements in the hamartomas. If
the epithelial clefts constitute the parenchyma element in
hamartomas, with the smooth muscle tissue and cartilage
being mere stroma, then one might expect to see karyotypic
similarities with adenomas. Only one adenoma of the lung
with cytogenetic abnormalities has been reported (Teyssier &
Ferre, 1989) and this tumour had no structural chromosome
changes. However, combining cytogenetic and immunological
techniques, Fletcher et al. (1991) obtained results indicating
that the chromosome aberrations in their pulmonary hamar-
toma cultures were present only in cells of mesenchymal
origin. Another piece of indirect evidence pointing in the
same direction is the fact that the growth pattern in the
short-term cultures we examined was overwhelmingly mesen-
chymal (data not shown).
There remains then the comparison with leiomyomas and
chondromas, the benign mesenchymal tumours whose his-
togenetic features correspond to the dominant tissue elements
in pulmonary hamartomas. Very little is known about the
chromosome aberrations of chondromas, but what inform-
ation there is indicates that the 12ql3-15 region is nonran-
domly involved (Mandahl et al., 1990; 1993). This would
then indicate some degree of similarity with pulmonary
hamartoma karyotypes, in the sense that they too seem to
have 12q rearrangements more often than chance would
allow (Fletcher et al., 1991; cases 3-5 in Table I).
The comparison between pulmonary hamartomas and leio-
myoma is much easier, in as much as uterine leiomyomas are
the benign tumours for which the most extensive cytogenetic
data exists. The most characteristic karyotypic rearrangement
in leiomyomas is t(12;14) (ql5;q24) (Heim et al., 1988; Turc-
Carel et al., 1988; Pandis et al., 1990), i.e., a rearrangement
affecting the same band in 14q that is also involved in the
6;14-translocation in hamartomas. Variant translocations are
relatively common and mostly consist of rearrangements of
12q without visible recombination with 14q (Nilbert & Heim,
1990). Variant changes of 14q, but not of 12q, have been
described in only five leiomyomas (Mugneret et al., 1988;
Mark et al., 1990; Nilbert et al., 1990; Kiechle-Schwarz et al.,
1991; Vanni et al., 1991). It is remarkable, however, that 14q
was recombined with 6p in two of these tumours, and in one
of them an ins(l4;6)(q23;p23p25) was found as the only
karyotypic anomaly. Finally, several cytogenetic subgroups
of leiomyoma without 12q and 14q changes have also been
described, tumours that seem to have evolved completely
outside the t(12;14) pathway. The most numerous of theseCHROMOSOMAL ABNORMALITIES IN HAMARTOMAS 1239
Figure 3 Representative karyogram from case 3. The rearrangements are der(l)ins(1;12)(p22p36;q24ql3) and t(6;17;13;14)
(p21;pl2;ql4;q24). The four-way translocation leads to the formation of the following derivative chromosomes; der(6)t(6;14), del
(13q), der(14)t(13;14), and der(17)t(6;17). Arrowheads indicate breakpoints.
subsets are defined by the presence of trisomy 12, del(7q),
and various rearrangements of 6p (Nilbert & Heim, 1990;
Nilbert et al., 1990; Pandis et al., 1991).
The above collation of leiomyoma and hamartoma cyto-
genetics points to the frequent rearrangement of 14q24 as the
main karyotypic similarity between the two tumours. The
standard translocation in leiomyomas is t(12;14), with most
variant translocations affecting 12q but not 14q. In contrast,
the standard translocation in hamartomas of the lung seems
to be t(6;14). Variants have been detected, involving both 6p
and 14q, with no obvious frequency differences emerging
until now. As far as chromosomes 6 and 12 are concerned,
there seems to exist a sort of inverse parallelism: Involvement
of 6p is a main feature of pulmonary hamartomas but is also
relatively common in leiomyomas (Nilbert et al., 1990),
whereas 12q changes predominate in leiomyomas but have
also been seen repeatedly in the few hamartomas hitherto
investigated.
Is the essential molecular outcome of t(6;14) in pulmonary
hamartoma identical to that of t(12;14) in uterine leiomy-
oma? As long as the DNA-, RNA-, and protein-level results
are not known for any of the translocations, the question
cannot be satisfactorily answered. Even if the same gene in
14q24 were affected in leiomyomas and hamartomas, which
we surmise but do not know, the variable translocation
partners could nevertheless ensure that crucially different
proteins are encoded, for instance if t(6;14) and t(12;14) both
lead to the formation of fusion genes. This would offer a
valid explanation for the phenotypic differences between the
highly heterogeneous hamartomas and the monomorphic
leiomyomas. It is not necessary to invoke molecular
differences to explain the various histologies of the two
tumour types, however; this could also be done by
hypothesising that the tumourigenic events hit cells at
different stages of pluripotentiality in different tumours. If
the 14q24 gene recombines with a gene in 6p2l or 12q15 in a
mesenchymal stem cell that is already committed to smooth
muscle differentiation, then a leiomyoma results. When, on
the other hand, the same event takes place in a more
primitive mesenchymal stem cell in the airways, the clone
emanating from this precursor cell may give rise to as diverse
tissues as cartilage and smooth muscle fibers, with a hamar-
toma as the result. The cytogenetic findings are compatible
with both scenarios, and regardless of which of them is more
correct, the epithelial elements would not be part of the
neoplastic parenchyma.
Having established that only the connective tissue cells are
truly neoplastic in pulmonary hamartomas, one also needs to
acknowledge the possibility - however remote it may seem -
that only one of the dominant mesenchymal tissue com-
ponents, not both, may constitute the neoplastic parenchyma.
The fact that cartilage makes up the bulk of most pulmonary
hamartomas, also in our series, can hardly be seen as a
reliable indicator as to which cells are the more important.
Although the karyotypic similarity at the present stage of
data collection seems to be more pronounced between ham-
artomas and leiomyomas than between hamartomas and
chondromas, all three groups have sufficient common fea-
tures to indicate a close pathogenetic relationship. Cyto-
genetic investigations can only contribute to the answering of
this question if combined with other investigative modalities.
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